Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2011
Mitotic inhibitors
Anne S Tsao, V Papadimitrakopoulou
Seminars in Radiation Oncology
|
January 5, 1999
Chemoprevention in head and neck cancer: basic science and clinical application
C Geyer, V Papadimitrakopoulou, W K Hong
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2017
Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies
H Tang, S Wang, G Xiao, et al.
Journal of Neuro-Oncology
|
January 1, 1993
Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas
F B Cvitkovic, C Haie-Meder, V Papadimitrakopoulou, et al.
Cancer Research
|
June 1, 1996
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma
S K Kim, Y Fan, V Papadimitrakopoulou, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2015
Innovative Clinical Trials: The LUNG-MAP Study
C E Steuer, V Papadimitrakopoulou, R S Herbst, et al.
Leukemia & Lymphoma
|
June 1, 1997
Primary parotid lymphoma: the effect of International Prognostic Index on outcome
A H Sarris, V Papadimitrakopoulou, M A Dimopoulos, et al.
Oncogene
|
April 17, 1997
Frequent inactivation of p16INK4a in oral premalignant lesions
V Papadimitrakopoulou, J Izzo, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma
E Massarelli, H Lin, L E Ginsberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2009
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
J-C Soria, F A Shepherd, J-Y Douillard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2011
Mitotic inhibitors
Anne S Tsao, V Papadimitrakopoulou
Seminars in Radiation Oncology
|
January 5, 1999
Chemoprevention in head and neck cancer: basic science and clinical application
C Geyer, V Papadimitrakopoulou, W K Hong
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2017
Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies
H Tang, S Wang, G Xiao, et al.
Journal of Neuro-Oncology
|
January 1, 1993
Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas
F B Cvitkovic, C Haie-Meder, V Papadimitrakopoulou, et al.
Cancer Research
|
June 1, 1996
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma
S K Kim, Y Fan, V Papadimitrakopoulou, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2015
Innovative Clinical Trials: The LUNG-MAP Study
C E Steuer, V Papadimitrakopoulou, R S Herbst, et al.
Leukemia & Lymphoma
|
June 1, 1997
Primary parotid lymphoma: the effect of International Prognostic Index on outcome
A H Sarris, V Papadimitrakopoulou, M A Dimopoulos, et al.
Oncogene
|
April 17, 1997
Frequent inactivation of p16INK4a in oral premalignant lesions
V Papadimitrakopoulou, J Izzo, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma
E Massarelli, H Lin, L E Ginsberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2009
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
J-C Soria, F A Shepherd, J-Y Douillard, et al.
Page
of 2